Detalhe da pesquisa
1.
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.
J Biol Chem
; 296: 100157, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273014
2.
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies.
Clin Cancer Res
; 26(8): 1953-1964, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31964784
3.
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
Neuro Oncol
; 20(9): 1185-1196, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982664